Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Studies of Hyperparathyroidism and Related Disorders
NCT00001277Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Dec 1993
- Primary completion
- Mar 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 dotatate, Fluorodopa F 18 in Multiple endocrine neoplasia type 1 (MEN1), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Dec 1993; status: completed.
02
Drugs
gallium ga 68 dotatateFluorodopa F 18
03
Conditions
Multiple endocrine neoplasia type 1 (MEN1)
Beyond the preview
Go deeper on NCT00001277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001277.